UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.64B |
| 2 |
Eaton
ETN
|
+$670M |
| 3 |
Hewlett Packard
HPE
|
+$663M |
| 4 |
SPDR Gold Trust
GLD
|
+$534M |
| 5 |
JPMorgan Chase
JPM
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$726M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$562M |
| 3 |
Microsoft
MSFT
|
+$557M |
| 4 |
Phillips 66
PSX
|
+$548M |
| 5 |
Boeing
BA
|
+$465M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.49% |
| 2 | Financials | 10% |
| 3 | Healthcare | 7.03% |
| 4 | Consumer Discretionary | 6.75% |
| 5 | Industrials | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
CALL
US Bancorp
USB
$100B
| $8.2M | ﹤0.01% |
194,300
+73,300
| +61% | +$3.38M |
|
3252
Supernus Pharmaceuticals
SUPN
$2.74B
| $8.2M | ﹤0.01% |
250,316
+50,290
| +25% | +$1.78M |
|
|
AVDX
3253
DELISTED
AvidXchange
AVDX
| $8.2M | ﹤0.01% |
966,552
-18,569
| -2% | -$172K |
|
3254
Suburban Propane Partners
SPH
$1.17B
| $8.16M | ﹤0.01% |
388,169
+51,663
| +15% | +$1.05M |
|
3255
NewAmsterdam Pharma
NAMS
$3.34B
| $8.15M | ﹤0.01% |
398,143
+317,933
| +396% | +$7.07M |
|
3256
Franklin FTSE United Kingdom ETF
FLGB
$930M
| $8.14M | ﹤0.01% |
283,905
-35,818
| -11% | -$997K |
|
3257
WaFd
WAFD
$2.76B
| $8.13M | ﹤0.01% |
284,551
+71,867
| +34% | +$2.13M |
|
3258
Fortuna Silver Mines
FSM
$3.18B
| $8.13M | ﹤0.01% |
1,333,143
-1,312
| -0.1% | -$6.52K |
|
3259
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
| $8.12M | ﹤0.01% |
373,615
+227,604
| +156% | +$4.87M |
|
3260
Barings BDC
BBDC
$980M
| $8.12M | ﹤0.01% |
850,829
+278,324
| +49% | +$2.75M |
|
3261
Schrodinger
SDGR
$1.4B
| $8.11M | ﹤0.01% |
410,940
+13,351
| +3% | +$300K |
|
3262
Scorpio Tankers
STNG
$3.83B
| $8.11M | ﹤0.01% |
215,675
+48,001
| +29% | +$2.15M |
|
3263
MYR Group
MYRG
$5.14B
| $8.1M | ﹤0.01% |
71,667
+32,325
| +82% | +$4.3M |
|
|
PCH
3264
DELISTED
PotlatchDeltic
PCH
| $8.1M | ﹤0.01% |
179,486
+631
| +0.4% | +$27.7K |
|
3265
CALL
Nu Holdings
NU
$67B
| $8.09M | ﹤0.01% |
789,600
+169,600
| +27% | +$2M |
|
3266
Vital Farms
VITL
$483M
| $8.08M | ﹤0.01% |
265,097
+28,617
| +12% | +$1.03M |
|
3267
PUT
DaVita
DVA
$11.7B
| $8.08M | ﹤0.01% |
52,800
-11,100
| -17% | -$1.74M |
|
|
DOO
3268
Bombardier Recreational Products
DOO
$4.7B
| $8.07M | ﹤0.01% |
238,726
+10,112
| +4% | +$445K |
|
3269
Madison Square Garden
MSGE
$3.69B
| $8.06M | ﹤0.01% |
246,299
+53,930
| +28% | +$1.88M |
|
3270
Otter Tail
OTTR
$3.88B
| $8.06M | ﹤0.01% |
100,289
-162,028
| -62% | -$12.8M |
|
3271
Avantis US Equity ETF
AVUS
$14.3B
| $8.05M | ﹤0.01% |
87,155
-13,914
| -14% | -$1.36M |
|
3272
Trinity Industries
TRN
$2.3B
| $8.03M | ﹤0.01% |
286,066
-62,389
| -18% | -$2.09M |
|
3273
Nuveen ESG International Developed Markets Equity ETF
NUDM
$724M
| $8.02M | ﹤0.01% |
251,727
-28,858
| -10% | -$916K |
|
3274
BlackRock Enhanced Captial and Income Fund
CII
$1.02B
| $8.02M | ﹤0.01% |
434,079
-29,870
| -6% | -$598K |
|
3275
Intellia Therapeutics
NTLA
$1.68B
| $8.01M | ﹤0.01% |
1,126,804
-614,964
| -35% | -$6.21M |
|
Similar funds
UBS Group's Q1 2025 Portfolio in Review
As of Q1 2025, UBS Group held 11,092 positions worth $544B, up 0.53% from $541B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $24.2B of net new capital in Q1 2025, opening 1,201 new positions and adding to 4,607 existing holdings. Its largest new stake was Sandisk: 3,424,800 shares worth $163M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Strategy Inc, an estimated $726M trimmed.
- UBS Group's largest Q1 2025 buy was Sandisk: 3,424,800 shares worth $163M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $1.64B increase.
- UBS Group's biggest Q1 2025 reduction was Strategy Inc, cutting an estimated $726M.
- UBS Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $432M.
- UBS Group's ten largest holdings make up 14% of its $544B portfolio in Q1 2025.
- UBS Group opened 1,201 new positions and closed 931 in Q1 2025.
- UBS Group's portfolio value rose 0.53% quarter-over-quarter to $544B.
Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.